TRPV2 and central nervous system cancer: TRPV2 was found to be expressed in benign astrocyte tissues, in glioma cell lines and in glioma tissues, with a marked reduction of TRPV2 in high-grade gliomas, suggesting that TRPV2 expression played a negative role in tumor progression.